These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

236 related items for PubMed ID: 8809241

  • 21. Liver transplantation for primary sclerosing cholangitis: timing, outcome, impact of inflammatory bowel disease and recurrence of disease.
    Wiesner RH.
    Best Pract Res Clin Gastroenterol; 2001 Aug; 15(4):667-80. PubMed ID: 11492975
    [Abstract] [Full Text] [Related]

  • 22. [Primary sclerosing cholangitis and inflammatory bowel disease].
    Schrumpf E, Fausa O, Aadland E, Elgjo K, Kolmannskog F.
    Tidsskr Nor Laegeforen; 1990 Apr 10; 110(10):1212-6. PubMed ID: 1970674
    [Abstract] [Full Text] [Related]

  • 23. Hepatobiliary associations with inflammatory bowel disease.
    Knight C, Murray KF.
    Expert Rev Gastroenterol Hepatol; 2009 Dec 10; 3(6):681-91. PubMed ID: 19929587
    [Abstract] [Full Text] [Related]

  • 24. Restorative proctocolectomy and ileal pouch-anal anastomosis for ulcerative colitis after liver transplant for primary sclerosing cholangitis: case report and review of literature.
    Grucela AL, Steinhagen RM.
    Am Surg; 2005 Apr 10; 71(4):362-5. PubMed ID: 15943415
    [Abstract] [Full Text] [Related]

  • 25. Changes over a 20-year period in the clinical presentation of primary sclerosing cholangitis in Sweden.
    Bergquist A, Said K, Broomé U.
    Scand J Gastroenterol; 2007 Jan 10; 42(1):88-93. PubMed ID: 17190768
    [Abstract] [Full Text] [Related]

  • 26. Prevalence of primary sclerosing cholangitis in ulcerative colitis patients undergoing proctocolectomy and ileal pouch-anal anastomosis.
    Lepistö A, Kärkkäinen P, Järvinen HJ.
    Inflamm Bowel Dis; 2008 Jun 10; 14(6):775-9. PubMed ID: 18253951
    [Abstract] [Full Text] [Related]

  • 27. The challenges in primary sclerosing cholangitis--aetiopathogenesis, autoimmunity, management and malignancy.
    Weismüller TJ, Wedemeyer J, Kubicka S, Strassburg CP, Manns MP.
    J Hepatol; 2008 Jun 10; 48 Suppl 1():S38-57. PubMed ID: 18304683
    [Abstract] [Full Text] [Related]

  • 28. Screening and diagnosis of cholangiocarcinoma in patients with primary sclerosing cholangitis.
    Jesudian AB, Jacobson IM.
    Rev Gastroenterol Disord; 2009 Jun 10; 9(2):E41-7. PubMed ID: 19668124
    [Abstract] [Full Text] [Related]

  • 29. Cholangiocarcinoma in young individuals with and without primary sclerosing cholangitis.
    Björnsson E, Angulo P.
    Am J Gastroenterol; 2007 Aug 10; 102(8):1677-82. PubMed ID: 17433022
    [Abstract] [Full Text] [Related]

  • 30. A retrospective single-center review of primary sclerosing cholangitis in children.
    Miloh T, Arnon R, Shneider B, Suchy F, Kerkar N.
    Clin Gastroenterol Hepatol; 2009 Feb 10; 7(2):239-45. PubMed ID: 19121649
    [Abstract] [Full Text] [Related]

  • 31. [Primary sclerosing cholangitis].
    Boonstra K, Ponsioen CI, Rauws EA, Beuers U.
    Ned Tijdschr Geneeskd; 2010 Feb 10; 154():A1476. PubMed ID: 20619015
    [Abstract] [Full Text] [Related]

  • 32. The risk of cancer and dysplasia among ulcerative colitis patients with primary sclerosing cholangitis.
    Marchesa P, Lashner BA, Lavery IC, Milsom J, Hull TL, Strong SA, Church JM, Navarro G, Fazio VW.
    Am J Gastroenterol; 1997 Aug 10; 92(8):1285-8. PubMed ID: 9260790
    [Abstract] [Full Text] [Related]

  • 33. Characterization and clinical course of hepatobiliary carcinoma in patients with primary sclerosing cholangitis.
    Tischendorf JJ, Meier PN, Strassburg CP, Klempnauer J, Hecker H, Manns MP, Krüger M.
    Scand J Gastroenterol; 2006 Oct 10; 41(10):1227-34. PubMed ID: 16990210
    [Abstract] [Full Text] [Related]

  • 34. High lifetime risk of cancer in primary sclerosing cholangitis.
    Claessen MM, Vleggaar FP, Tytgat KM, Siersema PD, van Buuren HR.
    J Hepatol; 2009 Jan 10; 50(1):158-64. PubMed ID: 19012991
    [Abstract] [Full Text] [Related]

  • 35. Duration of Inflammatory Bowel Disease Is Associated With Increased Risk of Cholangiocarcinoma in Patients With Primary Sclerosing Cholangitis and IBD.
    Gulamhusein AF, Eaton JE, Tabibian JH, Atkinson EJ, Juran BD, Lazaridis KN.
    Am J Gastroenterol; 2016 May 10; 111(5):705-11. PubMed ID: 27002801
    [Abstract] [Full Text] [Related]

  • 36. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis.
    Burak K, Angulo P, Pasha TM, Egan K, Petz J, Lindor KD.
    Am J Gastroenterol; 2004 Mar 10; 99(3):523-6. PubMed ID: 15056096
    [Abstract] [Full Text] [Related]

  • 37. Primary sclerosing cholangitis and malignancy.
    Boberg KM, Lind GE.
    Best Pract Res Clin Gastroenterol; 2011 Dec 10; 25(6):753-64. PubMed ID: 22117640
    [Abstract] [Full Text] [Related]

  • 38. The Fifth Carlos E. Rubio Memorial Lecture. Sclerosing cholangitis: pathogenesis, pathology, and practice.
    Larusso NF.
    P R Health Sci J; 1999 Mar 10; 18(1):11-7. PubMed ID: 10343981
    [Abstract] [Full Text] [Related]

  • 39. Relationship between clinical parameters and the colitis-colorectal cancer interval in a cohort of patients with colorectal cancer in inflammatory bowel disease.
    Brackmann S, Andersen SN, Aamodt G, Langmark F, Clausen OP, Aadland E, Fausa O, Rydning A, Vatn MH.
    Scand J Gastroenterol; 2009 Mar 10; 44(1):46-55. PubMed ID: 18609187
    [Abstract] [Full Text] [Related]

  • 40. Clinical differences between primary sclerosing cholangitis and sclerosing cholangitis with autoimmune pancreatitis.
    Nakazawa T, Ohara H, Sano H, Ando T, Aoki S, Kobayashi S, Okamoto T, Nomura T, Joh T, Itoh M.
    Pancreas; 2005 Jan 10; 30(1):20-5. PubMed ID: 15632695
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 12.